ClinicalTrials.govpublic full text
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
fallopian tube cancer, primary peritoneal cavity cancer, recurrent ovarian epithelial cancer, stage iv ovarian epithelial cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 897892
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.